Intellia Therapeutics
NTLA
NTLA
140 hedge funds and large institutions have $569M invested in Intellia Therapeutics in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 143 → 140 (-3)
15% less capital invested
Capital invested by funds: $669M → $569M (-$100M)
33% less call options, than puts
Call options by funds: $1.12M | Put options by funds: $1.67M
Holders
140
Holding in Top 10
2
Calls
$1.12M
Puts
$1.67M
Top Buyers
| 1 | +$18.3M | |
| 2 | +$3.1M | |
| 3 | +$2.26M | |
| 4 |
BlackRock
New York
|
+$1.8M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.2M |
Top Sellers
| 1 | -$3.71M | |
| 2 | -$3.7M | |
| 3 | -$2.93M | |
| 4 |
Two Sigma Investments
New York
|
-$1.52M |
| 5 |
3C
361 Capital
Denver,
Colorado
|
-$1.39M |